In one trial for semaglutide, participants taking a 2.4 mg once-weekly dose lost 14.9% of their body weight over 68 weeks compared to a weight reduction of 2.4% in the placebo group
Summary GLP-1 medications are approved in different doses to manage type 2 diabetes and high body weight
When sequence data are shown in supplier documentation, researchers should compare that sequence against authoritative or literature-backed sources rather than treating a product-page label as the only identity record
For patients concerned about tirzepatide costs, several resources can help
Wimalasekera R, Tebartz F, Scherer GFE (2011) Polyamines, polyamine oxidases and nitric oxide in development, abiotic and biotic stresses
zeina hydrophobins BST61_g1984 and BST61_g6910 are likely to have putative functions in the previously mentioned processes and that these processes occur as a result of the switch to necrotrophy